Skip to content

Effect of sesamin supplementation in rheumatoid arthritis women

Effect of sesamin supplementation on the serum levels of some proteolytic enzymes inflammatory , oxidative stress , cyclooxygenase 2 and lipid profile in rheumatoid arthritis women– triple blind Clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013111715424N1
Enrollment
44
Registered
2014-03-01
Start date
2013-10-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis. Seropositive rheumatoid arthritis

Interventions

Intervention 1: Intervention group: Sesamine supplement, 200 mg caps per day for 6 weeks. Intervention 2: Placebo group: placebo caps for 6 weeks.
Treatment - Drugs
Intervention group: Sesamine supplement, 200 mg caps per day for 6 weeks

Sponsors

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Willing to participate in study; Clinical diagnosis of rheumatoid arthritis (meeting the American college of rheumatology 1987 criteria); No smoking or addiction; No drug type and dose fluctuation since 1 month prior to the study and during intervention period ; Not having severe cardiovascular; hepatic; kidney; gastrointestinal; thyroid; parathyroid diseases; diabetes and inflammation; Not using medications except for AR conventional drugs; No pregnancy or lactation Exclusion criteria: developing illnesses which need particular cures or interfere with intervention such as increasing the disease activity or trauma; alcoholic; sensitivity to sesame

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total antioxidant capacity (TAC). Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.

Secondary

MeasureTime frame
TNF-alpha. Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.;Interlukin 6. Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Majid Mohamadshahi

Ahvaz Jundishapur University of medical sciences

Mohamadshahi-m@ajums.ac.ir+98 61 1333 7079

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026